Jonathan Cooper,
The Wolfson Chair of Bioengineering,
University of Glasgow
Professor Jon Cooper holds The Wolfson Chair in Biomedical Engineering. He is an EPSRC Research Fellow and holds a European Research Council Advanced Programme Grant. His major research interests are in ultrasonics, microfluidics and medical diagnostics. He has a track record of spin-out and translation of devices into practice. In one example, he is developing, rapid, zero-cost “origami paper” diagnostics species-specific DNA sensors to identify the cause of infectious disease and inform treatment “in the field” in Asia, India and Africa for point of care testing of infectious diseases in humans and animals from blood, sperm and faecal samples. He was elected as a Fellow of the Royal Academy of Engineering (UK’s national academy of engineering) as well as a Fellow of the Royal Society of Edinburgh (Scotland’s National Academy of arts, humanities and sciences).
Mobile Diagnostics - Multiplexed DNA Malaria Sensing using Origami Paper Folding and Blockchain/Expert AI Digital Healthcare Systems
Thursday, 10 September 2020 at 10:00
Add to Calendar ▼2020-09-10 10:00:002020-09-10 11:00:00Europe/LondonMobile Diagnostics - Multiplexed DNA Malaria Sensing using Origami Paper Folding and Blockchain/Expert AI Digital Healthcare SystemsPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Identification of the species of pathogen is often key to informing the treatment of patients with infectious diseases. Here, we use paper-based folding, in a manner similar to origami, to process patient samples from a finger-prick of blood and diagnose malaria amongst communities in rural villages. The design of the DNA sensing device means that testing can be done by a non-expert, integrating sample preparation into a multiplexed lateral flow device – akin to a conventional pregnancy test. We have tested our devices working with the Ministry of Health in Uganda, using a mobile phone to run the tests, collect and collate data and provide expert decision support for the healthcare workers. The technique has the potential to provide new diagnostic information that can direct therapy, thereby reducing the future threat of anti-microbial resistance. The tests could also find applications in identifying asymptomatic carriers with low levels of infection, thereby supporting the delivery of disease elimination programmes.
Add to Calendar ▼2020-09-09 00:00:002020-09-10 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2020Point-of-Care, Biosensors and Mobile Diagnostics Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com